NTLA stock
Intellia Therapeutics Inc [NTLA] Revenue clocked in at $57.53 million, down -38.30% YTD: What’s Next?
Intellia Therapeutics Inc [NASDAQ: NTLA] closed the trading session at $9.52 on 2025-11-07. The day’s price range saw the stock ...
why Intellia Therapeutics Inc [NTLA] is a Good Choice for Investors After New Price Target of $27.85
Intellia Therapeutics Inc [NASDAQ: NTLA] surged by $1.37 during the normal trading session on Wednesday and reaching a high of ...
For Intellia Therapeutics Inc [NTLA], Analyst sees a rise to $14. What next?
Intellia Therapeutics Inc [NASDAQ: NTLA] traded at a low on 2025-10-28, posting a -5.61 loss after which it closed the ...
For Intellia Therapeutics Inc [NTLA], Analyst sees a rise to $33. What next?
Intellia Therapeutics Inc [NASDAQ: NTLA] closed the trading session at $25.93 on 2025-10-15. The day’s price range saw the stock ...
Intellia Therapeutics Inc [NTLA] stock Upgrade by Citizens JMP analyst, price target now $33
Intellia Therapeutics Inc [NASDAQ: NTLA] traded at a high on 2025-10-08, posting a 19.72 gain after which it closed the ...
Market Analysts see Intellia Therapeutics Inc [NTLA] gaining to $21. Time to buy?
Intellia Therapeutics Inc [NASDAQ: NTLA] jumped around 0.68 points on Wednesday, while shares priced at $17.76 at the close of ...
Intellia Therapeutics Inc [NTLA] Stock trading around $12.27 per share: What’s Next?
Intellia Therapeutics Inc [NASDAQ: NTLA] traded at a high on 2025-09-16, posting a 6.05 gain after which it closed the ...
